Brain

Revitalist Announces Strategic Partnership with Sama Therapeutics to Advance Digital Human AI Agents for Precision Mental Health

Vancouver, British Columbia--(Newsfile Corp. - September 9, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO),...

JuneBrain Receives MDIC Advanced Manufacturing Clearing House Award; Selects Compliance Group to Implement Siemens Polarion Design Quality System

LIBERTYVILLE, Ill.--(BUSINESS WIRE)--#SaMD--JuneBrain is excited to announce our selection to receive a grant award from the Medical Device Innovation Consortium’s...

Zevra Therapeutics Presented New Data for Arimoclomol and OLPRUVA® (Sodium Phenylbutyrate) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium

New clinical efficacy and safety data for arimoclomol as a possible treatment for Niemann-Pick disease type C, including from long-term...

Prosthetic Robot Arm Market to Grow by USD 640 Million from 2024-2028 as Rising Amputation Cases Drive Revenue, AI Revolutionizing Market Landscape – Technavio Report

NEW YORK, Sept. 5, 2024 /PRNewswire/ -- Report with market evolution powered by AI- The global prosthetic robot arm market  size...

Revitalist Lifestyle and Wellness Ltd. Partners with Wake Network to Launch Lion’s Brain Supplements for Enhanced Mental Clarity and Wellbeing

Vancouver, British Columbia--(Newsfile Corp. - September 5, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO),...

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

NANJING, China, Sept. 5, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets...

error: Content is protected !!